Concepedia

Mark W. Zimmerman

MW

25

Publications

1.8K

Citations

19

H-Index

2013

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Boston Children's Hospital

St. Jude Children's Research Hospital

Whitehead Institute for Biomedical Research

Mark W. Zimmerman is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and developmental biology.

ORCID

Top concepts

Publications per year

2013–2024

25

Publications

25

Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry

Adam D. Durbin, Mark W. Zimmerman, Neekesh V. Dharia et al. · Nature Genetics · 2018 · 291 citations · Full text

, , +7

<i>MYC</i> Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification

Mark W. Zimmerman, Yu Liu, Shuning He et al. · Cancer Discovery · 2017 · 231 citations · Full text

EP300 Selectively Controls the Enhancer Landscape of <i>MYCN</i> -Amplified Neuroblastoma

Adam D. Durbin, Tingjian Wang, Virangika K. Wimalasena et al. · Cancer Discovery · 2021 · 149 citations · Full text

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

Christian Dubiella, Benika J. Pinch, Kazuhiro Koikawa et al. · Nature Chemical Biology · 2021 · 141 citations · Full text

, , +9

LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis

Shizhen Zhu, Xiaoling Zhang, Nina Weichert‐Leahey et al. · Cancer Cell · 2017 · 100 citations · Full text

, , +7

Rows per page

1–5 of 25